Analysed VIVANI MEDICAL INC (VANI:NASDAQ) News Sources
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
13-05-2026
yahoo.com
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
28-05-2026
yahoo.com
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
22-06-2026
yahoo.com
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
25-06-2026
yahoo.com
Vivani strikes reverse-merger agreement with ClearOne for BCI business
03-07-2026
medicaldevice-network.com
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
07-07-2026
yahoo.com
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
08-07-2026
pharmaceutical-technology.com
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
15-07-2026
marketbeat.com
What is the current price of VIVANI MEDICAL INC (VANI:NASDAQ)?
The current price of VIVANI MEDICAL INC (VANI:NASDAQ) is $1.41.
VIVANI MEDICAL INC (VANI:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIVANI MEDICAL INC (VANI:NASDAQ) since the previous trading day is $-0.01.
VIVANI MEDICAL INC (VANI:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIVANI MEDICAL INC (VANI:NASDAQ) since the previous trading day is -0.7042%.
What is the most recent average sentiment score for VIVANI MEDICAL INC (VANI:NASDAQ)?
The most recent average sentiment score for VIVANI MEDICAL INC (VANI:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for VIVANI MEDICAL INC (VANI:NASDAQ)?
The most recent sentiment for VIVANI MEDICAL INC (VANI:NASDAQ) is .
SEC-8K** Filing Available For VIVANI MEDICAL INC (VANI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.